Journal
JOURNAL OF IMMUNOLOGY
Volume 185, Issue 2, Pages 791-794Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1090051
Keywords
-
Categories
Funding
- Arthritis Research UK
Ask authors/readers for more resources
In the mid-1980s, new molecular tools enabled the biology of cytokine expression and regulation to be studied. Our group uncovered a TNF-dependent cascade in active rheumatoid synovium, suggesting that TNF might be a therapeutic target; this concept was supported in an animal model of the disease. The proof of concept was a series of clinical trials, which have led to marked changes in the therapy of human rheumatoid arthritis and subsequently of other diseases. The work with TNF clearly demonstrated the importance of cytokines in medicine as well as the capacity of mAbs (or receptor fusion proteins) to be used long-term in large populations, thus changing the therapeutic landscape. The Journal of Immunology, 2010, 185: 791-794.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available